Non-small-cell lung cancer--stalemate or progress?

Lung cancer is a major health problem, and each year the overall rate of death from this tobacco-inflicted disease increases. In a few countries, including the United States, the death rate has decreased slightly, reflecting changing attitudes toward cigarette smoking. Non–small-cell lung cancer, which includes adenocarcinoma, squamous-cell carcinoma, and large-cell carcinoma, accounts for 75 to 80 percent of all new cases of lung cancer; the remainder are due to small-cell lung cancer. In patients with non–small-cell lung cancer, the possibility of cure depends mainly on their suitability for surgical resection. Unfortunately, at the time of diagnosis, only about 30 percent . . .

[1]  S. Adak,et al.  A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group. , 2000, The New England journal of medicine.

[2]  T. Nakano,et al.  Phase II study of irinotecan (CPT-11) combined with etoposide (VP-16) for previously untreated extensive stage small cell lung cancer (ES-SCLC) , 2000 .

[3]  J. Minna,et al.  Molecular pathogenesis of lung cancer. , 1999, The Journal of thoracic and cardiovascular surgery.

[4]  J. Padilla,et al.  Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial. , 1999, Lung cancer.

[5]  F. Khuri,et al.  Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer. , 1999, Journal of the National Cancer Institute.

[6]  J. Roth,et al.  Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. , 1998, Lung cancer.

[7]  S. Anthony,et al.  Chemotherapy plus Radiotherapy Compared with Radiotherapy Alone in the Treatment of Locally Advanced, Unresectable, Non-Small-Cell Lung Cancer , 1996, Annals of Internal Medicine.

[8]  J. Pignon,et al.  Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer: A meta‐analysis , 1996, Cancer.

[9]  F. Shepherd Induction chemotherapy for locally advanced non-small cell lung cancer. , 1993, The Annals of thoracic surgery.